The securities litigation law firm of Brower Piven, A Professional
Corporation, announces that a class action lawsuit has been commenced in
the United States District Court for the District of Nevada on behalf of
purchasers of Galectin Therapeutics Inc. (“Galectin”) (NASDAQ: GALT)
publicly traded securities during the period between January 6, 2014 and
July 28, 2014, inclusive (the “Class Period”).
If you have suffered a loss from investment in Galectin securities
purchased on or after January 6, 2014 and held through the revelation of
negative information during and/or at the end of the Class Period, as
described below, and would like to learn more about this lawsuit and
your ability to participate as a lead plaintiff, without cost or
obligation to you, please visit our website at http://www.browerpiven.com/currentsecuritiescases.html .
for - SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Galectin Therapeutics Inc. To Contact Brower Piven Before The September 29, 2014 Lead Plaintiff Deadline In Class Action Lawsuit investment picks